Share: Facebook Twitter LinkedIn
Activity Provided By:

CEimpact

What's New in Type 2: The 2021 Diabetes Update (Pharmacist)

Access Activity

Overview / Abstract:

Evidence-based guidelines and recommendations for the prevention, early detection, and treatment of diabetes are critical to optimal health and outcomes for people with diabetes. It is well known that monotherapy cannot achieve glycemic control for many people. When initiating a second-line therapy, clinicians must select among several treatment options and look beyond glycemic lowering. This interactive session will discuss the evidence and best practices of care for people with diabetes, including a review of current American Diabetes Association pharmacotherapy standards of care and the preferred treatment options to improve A1c, cardio-metabolic and renal health, and reduce the risks associated with diabetes.

Expiration

Feb 01, 2024

Discipline(s)

Pharmacy CPE

Format

Online, Webinar / Webcast / Video

Cost

9.00

Credits / Hours

0.10

Accreditation

ACPE

Presenters / Authors / Faculty

Susan Cornell, PharmD, CDCES, FAPhA, FADCES
Associate Director
Midwestern University College of Pharmacy

Keywords / Search Terms

CEimpact CEimpact CEI Impact CEI ce, antibiotics, antimicrobial stewardship, joint commission

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map